AVITA Medical, Inc. (RCEL)
Data as of , from SEC Form 4 filings.
See up to 3 months of RCEL. The 7-day demo opens the 1M and 3M ranges and puts RCEL on your watchlist.
Start 7-day demoLatest RCEL insider trades
About AVITA Medical, Inc. (RCEL)
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
- VALENCIA, CA
- 226
- 2012
- XNAS
RCEL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 2,000 | $8K |
RCEL insider transactions (Form 4)
4928 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $3.97 | $8K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 2,000 | $3.97 | $8K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,200 | $4.00 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.20 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.18 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.10 | $20K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.09 | $20K | |
| Robert McNamara | Grant or award | Common Stock | 22,214 | - footnote F1 | - | |
| Robert McNamara | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
| Joseph Fralin Woody | Grant or award | Common Stock | 40,547 | - footnote F1 | - | |
| Joseph Fralin Woody | Grant or award | Common Stock | 22,214 | - footnote F3 | - | |
| Joseph Fralin Woody | Grant or award | Stock Options (Right to Buy) | 29,446 | $0.00 | - | |
| Joseph Fralin Woody | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
 Michael E. Tarnoff | Grant or award | Common Stock | 26,250 | - footnote F1 | - | |
| Michael E. Tarnoff | Grant or award | Common Stock | 22,214 | - footnote F3 | - | |
| Michael E. Tarnoff | Grant or award | Stock Options (Right to Buy) | 19,063 | $0.00 | - | |
| Michael E. Tarnoff | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
| Jeremy Curnock Cook | Grant or award | Common Stock | 22,214 | - footnote F1 | - | |
| Jeremy Curnock Cook | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
| Suzanne Crowe | Grant or award | Common Stock | 22,214 | - footnote F1 | - | |
| Suzanne Crowe | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
 Jan Stern Reed | Grant or award | Common Stock | 22,214 | - footnote F1 | - | |
| Jan Stern Reed | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| ||||||
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.34 | $22K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.26 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.18 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.21 | $21K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 5,000 footnote F1 | $3.05 footnote F1 | $15K | |
| ||||||
| Cary Guy Vance - Officer | Grant or award | Common Stock | 5,000 footnote F1 | $3.05 footnote F1 | $15K | |
| ||||||
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.26 | $9K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.24 | $8K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 1,800 | $4.78 | $9K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 3,000 | $4.15 | $12K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 105,470 | - footnote F1 | - | |
| David D. O'Toole - Officer | Grant or award | Stock Options (Right to Buy) | 155,510 | $0.00 | - | |
| ||||||
| Nicole Kelsey - Officer | Grant or award | Common Stock | 98,390 | - footnote F1 | - | |
| Nicole Kelsey - Officer | Grant or award | Stock Options (Right to Buy) | 145,060 | $0.00 | - | |
| ||||||
| Robert McNamara | Open-market purchase | Common Stock | 10,000 | $4.50 | $45K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.52 | $9K | |
| Robert McNamara | Open-market purchase | Common Stock | 10,000 | $5.00 | $50K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.81 | $10K | |
| James Corbett - Officer | Grant or award | Stock Options (Right to Buy) | 520,000 | $0.00 | - | |
| Jeremy Curnock Cook | Grant or award | Common Stock | 10,022 | - | - | |
| Jeremy Curnock Cook | Grant or award | Stock Options (Right to Buy) | 4,295 | $0.00 | - | |
| Jan Stern Reed | Grant or award | Common Stock | 10,022 | - | - | |
| Jan Stern Reed | Grant or award | Stock Options (Right to Buy) | 4,295 | $0.00 | - | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 785 | $7.83 | $6K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 475 | $12.53 | $6K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 500 | $12.40 | $6K | |
Item 1.01, 9.01
Item 5.07
Item 2.02, 9.01
Item 1.01, 9.01
RCEL insider trading FAQ
What is the latest insider trade for RCEL?
AVITA Medical, Inc. (RCEL) had 1 insider filing in the last 90 days, with the most recent on 2026-08-24. The full record for RCEL runs to 28 Form 4 filings, the earliest from 2024-12-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RCEL stock?
1 insider purchase of RCEL was filed in the last 90 days, totaling $8K.
How many insiders are selling RCEL stock?
No insider sales of RCEL were filed in the last 90 days.
Where can I see RCEL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RCEL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David D. O'Toole view on EDGAR
- - David D. O'Toole view on EDGAR
- - Joseph Fralin Woody view on EDGAR
- - Joseph Fralin Woody view on EDGAR
- - Joseph Fralin Woody view on EDGAR
- - Robert McNamara view on EDGAR
- - Joseph Fralin Woody view on EDGAR
- - Michael E. Tarnoff view on EDGAR
- - Jeremy Curnock Cook view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where RCEL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RCEL with a 7-day demo
- RCEL on your watchlist
- Every RCEL Form 4 filing on record
- Up to 3 months of RCEL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
